These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33870710)

  • 1. Risk Factors and Outcomes of Recurrent Drug-Eluting Stent Thrombosis: Insights From the REAL-ST Registry.
    Enomoto S; Kuramitsu S; Shinozaki T; Ohya M; Otake H; Yamanaka F; Shiomi H; Natsuaki M; Nakazawa G; Ando K; Kadota K; Saito S; Tamura T; Kimura T;
    J Am Heart Assoc; 2021 May; 10(9):e018972. PubMed ID: 33870710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors and Long-Term Clinical Outcomes of Second-Generation Drug-Eluting Stent Thrombosis.
    Kuramitsu S; Ohya M; Shinozaki T; Otake H; Horie K; Kawamoto H; Yamanaka F; Natsuaki M; Shiomi H; Nakazawa G; Ando K; Kadota K; Saito S; Kimura T
    Circ Cardiovasc Interv; 2019 Jun; 12(6):e007822. PubMed ID: 31177822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes After First- Versus Second-Generation Drug-Eluting Stent Thrombosis (from the REAL-ST Registry).
    Horie K; Kuramitsu S; Shinozaki T; Ohya M; Otake H; Yamanaka F; Shiomi H; Natsuaki M; Nakazawa G; Tada N; Ando K; Kadota K; Saito S; Kimura T;
    Am J Cardiol; 2020 Oct; 132():52-58. PubMed ID: 32768142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and outcomes of recurrent stent thrombosis: results from a multicenter registry.
    Armstrong EJ; Sab S; Singh GD; Lim W; Yeo KK; Waldo SW; Patel M; Reeves R; MacGregor JS; Low RI; Shunk KA; Mahmud E; Rogers JH
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1105-13. PubMed ID: 25341707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
    Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent thrombosis with second- versus first-generation drug-eluting stents in real-world percutaneous coronary intervention: analysis of 3806 consecutive procedures from a large-volume single-center prospective registry.
    Dores H; Raposo L; Campante Teles R; Machado C; Leal S; Araújo Gonçalves P; Mesquita Gabriel H; Sousa Almeida M; Mendes M
    J Invasive Cardiol; 2013 Jul; 25(7):330-6. PubMed ID: 23813060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES.
    Brodie BR; Garg A; Stuckey TD; Kirtane AJ; Witzenbichler B; Maehara A; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Mehran R; Parvataneni R; Stone GW
    Circ Cardiovasc Interv; 2015 Oct; 8(10):. PubMed ID: 26415600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents.
    Varenhorst C; Lindholm M; Sarno G; Olivecrona G; Jensen U; Nilsson J; Carlsson J; James S; Lagerqvist B
    Clin Res Cardiol; 2018 Sep; 107(9):816-823. PubMed ID: 29667015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
    Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
    Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.
    Sarno G; Lagerqvist B; Nilsson J; Frobert O; Hambraeus K; Varenhorst C; Jensen UJ; Tödt T; Götberg M; James SK
    J Am Coll Cardiol; 2014 Jul; 64(1):16-24. PubMed ID: 24998123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry).
    Kawecki D; Morawiec B; Dola J; Wanha W; Smolka G; Pluta A; Marcinkiewicz K; Ochała A; Nowalany-Kozielska E; Wojakowski W
    Arq Bras Cardiol; 2016 May; 106(5):373-81. PubMed ID: 27058257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents.
    Maehara A; Mintz GS; Witzenbichler B; Weisz G; Neumann FJ; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Stuckey TD; Mazzaferri EL; McAndrew T; Généreux P; Mehran R; Kirtane AJ; Stone GW
    Circ Cardiovasc Interv; 2018 Nov; 11(11):e006243. PubMed ID: 30571206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial.
    Farooq V; Serruys PW; Zhang Y; Mack M; Ståhle E; Holmes DR; Feldman T; Morice MC; Colombo A; Bourantas CV; de Vries T; Morel MA; Dawkins KD; Kappetein AP; Mohr FW
    J Am Coll Cardiol; 2013 Dec; 62(25):2360-2369. PubMed ID: 24140677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcomes of Biodegradable Versus Second-Generation Durable Polymer Drug-Eluting Stent Implantations for Myocardial Infarction.
    Choe JC; Cha KS; Lee JG; Kim J; Shin JY; Ahn J; Park JS; Lee HW; Oh JH; Choi JH; Lee HC; Hong TJ; Jeong MH;
    JACC Cardiovasc Interv; 2020 Jan; 13(1):97-111. PubMed ID: 31918948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between stent thrombosis and calcium channel blocker after drug-eluting stent implantation: Kumamoto Intervention Conference Study (KICS) registry.
    Nagano M; Hokimoto S; Nakao K; Kaikita K; Akasaka T; Ogawa H;
    J Cardiol; 2015 Oct; 66(4):333-40. PubMed ID: 25572022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of late and very late thrombosis of drug eluting stents.
    Mishkel GJ; Moore AL; Markwell S; Shelton ME
    Am Heart J; 2008 Jul; 156(1):141-7. PubMed ID: 18585509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry.
    Takahashi Y; Otake H; Kuramitsu S; Ohya M; Horie K; Kawamoto H; Yamanaka F; Natsuaki M; Shiomi H; Nakazawa G; Ando K; Kadota K; Saito S; Kimura T
    EuroIntervention; 2022 Oct; 18(9):749-758. PubMed ID: 35389345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.